5th Edition of Addiction World Conference 2026

Abstract

The aging population is increasingly susceptible to neurodegenerative disorders and substance use disorders, necessitating innovative approaches to treatment. Cannabinol (CBN), a cannabinoid derived from the Cannabis sativa plant, has emerged as a promising candidate for addressing cognitive decline and addiction-related issues in geriatric patients. This presentation aims to explore the potential of CBN in enhancing brain health among older adults, particularly its neuroprotective properties and ability to modulate addictive behaviors. Recent studies suggest that CBN may promote neurogenesis, reduce inflammation, and alleviate anxiety—factors that are critical in both cognitive decline and addiction pathways. Furthermore, CBN’s interaction with the endocannabinoid system offers a unique mechanism for mitigating withdrawal symptoms and cravings associated with substance use disorders. By integrating CBN into geriatric care protocols, we can potentially improve outcomes for elderly patients struggling with addiction while simultaneously supporting cognitive health. This presentation will review current literature on CBN’s pharmacological effects, discuss clinical implications for geriatric psychiatry, and propose future research directions aimed at establishing CBN as a mainstream therapeutic option in addiction treatment within the aging population.